Revision as of 19:55, 4 September 2012 by WikiBot(talk | contribs)(Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
Natural cytotoxicity triggering receptor 1, also known as NCR1, is a human gene.[1] NCR1 has also been designated as CD335 (cluster of differentiation 335).
Biassoni R, Cantoni C, Marras D; et al. (2004). "Human natural killer cell receptors: insights into their molecular function and structure". J. Cell. Mol. Med. 7 (4): 376–87. PMID14754506.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Sivori S, Vitale M, Morelli L; et al. (1997). "p46, a novel natural killer cell-specific surface molecule that mediates cell activation". J. Exp. Med. 186 (7): 1129–36. PMID9314561.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Vitale M, Bottino C, Sivori S; et al. (1998). "NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis". J. Exp. Med. 187 (12): 2065–72. PMID9625766.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Pessino A, Sivori S, Bottino C; et al. (1998). "Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity". J. Exp. Med. 188 (5): 953–60. PMID9730896.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Cantoni C, Bottino C, Vitale M; et al. (1999). "NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily". J. Exp. Med. 189 (5): 787–96. PMID10049942.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Vankayalapati R, Wizel B, Weis SE; et al. (2002). "The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium". J. Immunol. 168 (7): 3451–7. PMID11907104.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID12477932.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Augugliaro R, Parolini S, Castriconi R; et al. (2003). "Selective cross-talk among natural cytotoxicity receptors in human natural killer cells". Eur. J. Immunol. 33 (5): 1235–41. doi:10.1002/eji.200323896. PMID12731048.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Ponassi M, Cantoni C, Biassoni R; et al. (2003). "Structure of the human NK cell triggering receptor NKp46 ectodomain". Biochem. Biophys. Res. Commun. 309 (2): 317–23. PMID12951052.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Foster CE, Colonna M, Sun PD (2003). "Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors". J. Biol. Chem. 278 (46): 46081–6. doi:10.1074/jbc.M308491200. PMID12960161.CS1 maint: Multiple names: authors list (link)
Arnon TI, Achdout H, Lieberman N; et al. (2004). "The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46". Blood. 103 (2): 664–72. doi:10.1182/blood-2003-05-1716. PMID14504081.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Marcenaro E, Augugliaro R, Falco M; et al. (2004). "CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity". Eur. J. Immunol. 33 (12): 3367–76. doi:10.1002/eji.200324425. PMID14635045.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Carbone E, Neri P, Mesuraca M; et al. (2005). "HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells". Blood. 105 (1): 251–8. doi:10.1182/blood-2004-04-1422. PMID15328155.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID15489334.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Mavoungou E, Bouyou-Akotet MK, Kremsner PG (2005). "Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30)". Clin. Exp. Immunol. 139 (2): 287–96. doi:10.1111/j.1365-2249.2004.02686.x. PMID15654827.CS1 maint: Multiple names: authors list (link)
Nowbakht P, Ionescu MC, Rohner A; et al. (2005). "Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias". Blood. 105 (9): 3615–22. doi:10.1182/blood-2004-07-2585. PMID15657183.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Poggi A, Massaro AM, Negrini S; et al. (2005). "Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors". J. Immunol. 174 (5): 2653–60. PMID15728472.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Zilka A, Landau G, Hershkovitz O; et al. (2006). "Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46". Biochemistry. 44 (44): 14477–85. doi:10.1021/bi051241s. PMID16262248.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Hermann E, Alonso-Vega C, Berthe A; et al. (2006). "Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells". Pediatr. Res. 60 (1): 38–43. doi:10.1203/01.pdr.0000220335.05588.ea. PMID16690951.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)